Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
15th week of 2022 patent applcation highlights part 7
Patent application number
Title
Published
20220110838
ORAL CARE NANOPARTICLE COMPOSITIONS AND METHODS
2022-04-14
20220110839
COMPOSITION COMPRISING HECTORITE AND PECTIN
2022-04-14
20220110840
BIOBASED THICKENING COMPOSITION COMPRISING A POLY(FARNESENE)
2022-04-14
20220110841
COSMETIC PREPARATION IN GEL FORM
2022-04-14
20220110842
DMS (derma membrane structure) in Foam Creams
2022-04-14
20220110843
AN ORAL REMINERALIZATION ACCELERATING COMPOSITION
2022-04-14
20220110844
Peroxide Gel Compositions
2022-04-14
20220110845
BOTANICAL COMPOSITIONS
2022-04-14
20220110846
EMOLLIENT AND CLEANSING AGENT
2022-04-14
20220110847
USE OF COOLING MATERIALS FOR THE REDUCTION OR INHIBITION OF SALTINESS IN ORALLY ADMINISTERED, IMBIBED OR INGESTED CONSUMER PRODUCTS
2022-04-14
20220110848
PHOTOPROTECTIVE COMPOSITIONS CONTAINING MALASSEZIA-DERIVED COMPOUNDS AND/OR CHEMICAL ANALOGS THEREOF
2022-04-14
20220110849
PERFUME PROLONGER
2022-04-14
20220110850
LECITHIN-CONTAINING COSMETIC BASE MATERIAL AND COSMETIC PREPARATION IN WHICH SAME IS BLENDED
2022-04-14
20220110851
ACETYLCHOLINE RECEPTOR INHIBITORY PEPTIDES AND USES THEREOF
2022-04-14
20220110852
Pigment Stabilizers
2022-04-14
20220110853
IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS
2022-04-14
20220110854
Cosmetic Formulation
2022-04-14
20220110855
TOPICAL BARRIER COMPOSITION FOR DERMAL APPLICATION
2022-04-14
20220110856
A TRANSPARENT THICKENING BLEND
2022-04-14
20220110857
SOLID SOAP
2022-04-14
20220110858
AFFECTION GOLD HAIR CARE COMPOSITION AND METHOD
2022-04-14
20220110859
COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION
2022-04-14
20220110860
TRANSDERMAL FORMULATIONS
2022-04-14
20220110861
PHARMACEUTICAL FORMULATIONS OF TROPOMYOSIN RELATED KINASE (TRK) INHIBITORS
2022-04-14
20220110862
TREATMENT OF COGNITIVE DYSFUNCTION WITH PYRROLOPYRIDINE-ANILINE COMPOUNDS
2022-04-14
20220110863
POLYMER COMPOSITE FOR CONTROLLED RELEASE OF AN AGENT
2022-04-14
20220110864
FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM
2022-04-14
20220110865
METHOD FOR MANUFACTURING ORALLY DISINTEGRATING TABLET, AND ORALLY DISINTEGRATING TABLET
2022-04-14
20220110866
COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES
2022-04-14
20220110867
METHODS AND SYSTEMS FOR FORMING MULTI-LAYERED PARTICLES
2022-04-14
20220110868
TOPICAL COMPOSITION
2022-04-14
20220110869
TOPICAL MINOCYCLINE FOAMABLE COMPOSITIONS
2022-04-14
20220110870
LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
2022-04-14
20220110871
PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
2022-04-14
20220110872
ANTIBODY FORMULATIONS
2022-04-14
20220110873
Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement
2022-04-14
20220110874
METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITIONS
2022-04-14
20220110875
PHARMACEUTICAL COMPOSITION, COMPRISING PHOSPHATE BINDER PARTICLES
2022-04-14
20220110876
Gastro-Retentive Sustained-Release Oral Dosage Form of a Bile Acid Sequestrant
2022-04-14
20220110877
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
2022-04-14
20220110878
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
2022-04-14
20220110879
IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
2022-04-14
20220110880
NANOHELIX-SUBSTRATE COMPLEX FOR CONTROLLING MACROPHAGE BEHAVIOR, PREPARATION METHOD THEREOF, AND METHOD OF CONTROLLING ADHESION AND POLARIZATION OF MACROPAGE BY USING THE SAME
2022-04-14
20220110881
COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
2022-04-14
20220110882
SYNTHETICALLY LETHAL NANOPARTICLES FOR TREATMENT OF CANCERS
2022-04-14
20220110883
ANTI-TUMOR PLATINUM-BASED DRUG MINERALIZED PROTEIN NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOF
2022-04-14
20220110884
PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES
2022-04-14
20220110885
TRANSDERMAL THERAPEUTICS SYSTEM WITH BARRIER LAYER
2022-04-14
20220110886
OPTIMIZATION OF SCENT OR FLAVOR COMPOSITIONS
2022-04-14
20220110887
COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE THEREOF
2022-04-14
20220110888
COMPOSITION FOR THE TREATMENT OF PSORIASIS
2022-04-14
20220110889
R-KETAMINE AND DERIVATIVE THEREOF AS PROPHYLACTIC OR THERAPEUTIC AGENT FOR NEURODEVELOPMENTAL DISORDER
2022-04-14
20220110890
METHODS FOR TREATING CANCER
2022-04-14
20220110891
EPINEPHRINE COMPOSITIONS AND CONTAINERS
2022-04-14
20220110892
COMPOSITIONS COMPRISING EPHEDRINE OR AN EPHEDRINE SALT AND METHODS OF MAKING AND USING SAME
2022-04-14
20220110893
METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
2022-04-14
20220110894
Methods of Treating IgA Nephropathy with Thiol-Containing Molecules
2022-04-14
20220110895
BETA-HYDROXYBUTYRATE MIXED SALT COMPOSITIONS AND METHODS OF USE
2022-04-14
20220110896
COMPOSITIONS AND METHODS FOR PROVIDING SUSTAINED NATURAL SLEEP
2022-04-14
20220110897
COMPOSITIONS AND METHODS FOR TREATING BIOFILMS
2022-04-14
20220110898
TREATMENT OF STK11-LOSS CANCERS
2022-04-14
20220110899
COMPOSITIONS COMPRISING AMINO ACIDS FOR USE AND TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES
2022-04-14
20220110900
SOLID NUTRIENT COMPOSITIONS AND ASSOCIATED METHODS
2022-04-14
20220110901
FATTY ACID AMIDES AND USES THEREOF IN THE TREATMENT OF NAUSEA
2022-04-14
20220110902
Methods of treating amyloid-beta peptide diseases
2022-04-14
20220110903
COMPOSITIONS AND METHODS FOR PREVENTING, ALLEVIATING, AND TREATING NEUROLOGICAL INJURY FOLLOWING HEAD TRAUMA
2022-04-14
20220110904
FIXED DOSE COMBINATIONS AND FORMULATIONS COMPRISING ETC1002 AND ONE OR MORE STATINS AND METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE
2022-04-14
20220110905
Efficient anti-bacterial hydroxy acid ester oligomer
2022-04-14
20220110906
ANTIMICROBIAL DENTAL APPLIANCE
2022-04-14
20220110907
COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE
2022-04-14
20220110908
Low-Dose Doxepin Formulations And Methods Of Making And Using The Same
2022-04-14
20220110909
PREPARATION METHOD AND USE OF MODIFIED HYDROPHOBIC EXCIPIENT
2022-04-14
20220110910
CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF CYTOKINE RELEASE SYNDROME WHILE PRESERVING KEY ANTI-VIRAL IMMUNE REACTIONS
2022-04-14
20220110911
CANNABINOID COMPOSITION AND PROCESSES OF MANUFACTURE
2022-04-14
20220110912
CANNABINOID LOZENGE FORMULATION
2022-04-14
20220110913
PHARMACEUTICAL COMPOSITION COMPRISING FLT3 INHIBITOR AND HYPOMETHYLATING AGENT FOR TREATING ACUTE MYELOID LEUKEMIA
2022-04-14
20220110914
TITRATION OF CEBRANOPADOL
2022-04-14
20220110915
EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION
2022-04-14
20220110916
Antioxidant and Use Thereof
2022-04-14
20220110917
USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS
2022-04-14
20220110918
COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN-RELATED DISEASES AND PROMOTING DERMATOLOGICAL HEALTH
2022-04-14
20220110919
METHODS OF MODULATING LEUKOCYTES ACTIVATION AND THROMBOCYTE CLEARANCE WITH INHIBITORS OF SPECIFIC NEURAMINIDASE ISOENZYMES
2022-04-14
20220110920
COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL DISORDERS
2022-04-14
20220110921
NEW COMPOUNDS AND THEIR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF DISEASES INVOLVING THE RETINAL PIGMENT EPITHELIUM
2022-04-14
20220110922
TREATMENT OF CILIOPATHIES USING INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE (GCS)
2022-04-14
20220110923
ESTERS AND CARBAMATES AS MODULATORS OF SODIUM CHANNELS
2022-04-14
20220110924
METHODS AND COMPOSITIONS FOR GENETIC MODULATION OF TUMOR MICROENVIRONMENTS
2022-04-14
20220110925
Non-Aqueous Liquid Nimodipine Compositions
2022-04-14
20220110926
Non-Aqueous Liquid Nimodipine Compositions
2022-04-14
20220110927
FORMULATIONS CONTAINING DOMPERIDONE
2022-04-14
20220110928
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALD- EHYDE
2022-04-14
20220110929
FORMULATIONS CONTAINING DEUTERATED DOMPERIDONE
2022-04-14
20220110930
Composition Containing The Salsolinol For Treating Liver Cancer
2022-04-14
20220110931
BACE1 INHIBITORY LIGAND MOLECULES AGAINST AMYLOID BETA-INDUCED SYNAPTIC AND MITOCHONDRIAL TOXICITIES
2022-04-14
20220110933
METHODS OF TREATING DISEASE WITH MAGL INHIBITORS
2022-04-14
20220110934
PHARMACEUTICAL COMPOSITION
2022-04-14
20220110935
Cancer Treatment
2022-04-14
20220110936
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NEURODEGENERATIVE DISEASES OR DISEASES CAUSED BY ABNORMALITY OF RNA BINDING PROTEIN AND APPLICATIONS THEREOF
2022-04-14
20220110937
REGULATION OF eIF4E ACTIVITY FOR MIGRAINE THERAPY
2022-04-14
20220110938
Combination Therapy for Use in Treating Retroviral Infections
2022-04-14